supplementary tables S1-11 from Plasma Autoantibodies Associated with Basal-like Breast Cancers

supplementary tables S1-11. Table S1. Established breast cancer risk factors in the Polish Breast Cancer Study (basal-like, n=145; control, n=145)a. Table S2. AAb responses based on quantitative analysis in each sample from sample set 1. Table S3. AAb responses based on visual analysis in each sample from sample set 1. Table S4. List of proteins selected for focused array Table S5. List of 14 antigens selected from focused array experiments. Individual sensitivities were determined at 98% specificity (Sample set 2: basal-like, n=50; control, n=50). Table S6. List of proteins selected for ELISA verification Table S7. List of 15 antigens selected from ELISA verification. Individual sensitivities were determined at 98% specificity. (Sample set 1: basal-like, n=43; control, n=43). Table S8. 13-AAb classifier. Table S9. Performance of 13 AAbs in multiple breast cancer subtypes. (Basal-like, n=145; luminal A, n=30; luminal B, n=22; her2-enriched, n=18; control, n=145). Table S10. Relationship between TP53 AAb response and TP53 tissue IHC score in basal-like breast cancers. Table S11. Hazard ratios for 2 antigen AAb responses that are significantly associated with survival amongst 145 basal like breast cancers.